SEHK:6938Biotechs
Shrinking Losses At Suzhou Ribo Life Science (SEHK:6938) Test Bearish Profitability Narratives
Setting the Scene: Suzhou Ribo Life Science's Latest Numbers
Suzhou Ribo Life Science (SEHK:6938) has posted another loss for FY 2025, with first half revenue of ¥103.8 million and a basic EPS loss of ¥0.68, while trailing twelve month revenue sits at ¥148.5 million against a TTM EPS loss of ¥2.11. Looking back, revenue has moved from ¥66.3 million in 1H 2024 to ¥76.3 million in 2H 2024 and then to ¥103.8 million in 1H 2025, while basic EPS losses over these halves have gone from ¥1.07 to...